Clinical Trial Update: Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women [Phase 2]

View source ↗

Summary

Phase 2 trial comparing intravenous ferric carboxymaltose to IV iron sucrose or IV iron dextran for iron deficiency anemia in women has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)
• Iron Dextran (iron dextran)
• Iron sucrose (iron sucrose)

Snippet

Sponsor: American Regent, Inc. | Conditions: Iron Deficiency Anemia | Phase 2 | Status: COMPLETED | Results posted: 2018-02-08